UY30227A1 - Composiciones y métodos para aumentar la vasodilatacion - Google Patents
Composiciones y métodos para aumentar la vasodilatacionInfo
- Publication number
- UY30227A1 UY30227A1 UY30227A UY30227A UY30227A1 UY 30227 A1 UY30227 A1 UY 30227A1 UY 30227 A UY30227 A UY 30227A UY 30227 A UY30227 A UY 30227A UY 30227 A1 UY30227 A1 UY 30227A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions
- methods
- nitric oxide
- achieve
- pathways
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000024883 vasodilation Effects 0.000 title abstract 2
- 206010047141 Vasodilatation Diseases 0.000 title 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 4
- 230000037361 pathway Effects 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 229940072440 bovine lactoferrin Drugs 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000005086 pumping Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 235000014268 sports nutrition Nutrition 0.000 abstract 1
- 230000008719 thickening Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporcionan composiciones y méetodos para lograr la vasodilatacion a través de vías de produccion de oxido nítrico y vías de inhibicion de la angiotensina II utilizando lactoferrina bovina y péptidos que inhiben la enzima convertidora de angiotensina derivados del suero. Asimismo, se pueden agregar otros ingredientes de oxido nítrico para aplicaciones en la nutricion deportiva. Tales composiciones y métodos logran un "bombeo" que representa el aumento del flujo sanguíneo y el engrosamiento de los musculos causado por la sangre.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74357906P | 2006-03-20 | 2006-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30227A1 true UY30227A1 (es) | 2007-10-31 |
Family
ID=38457812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30227A UY30227A1 (es) | 2006-03-20 | 2007-03-20 | Composiciones y métodos para aumentar la vasodilatacion |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080038320A1 (es) |
AR (1) | AR059992A1 (es) |
PE (1) | PE20080037A1 (es) |
UY (1) | UY30227A1 (es) |
WO (1) | WO2007109681A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080268038A1 (en) * | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
US7790688B2 (en) * | 2008-01-11 | 2010-09-07 | Healthspan Solutions, Llc | Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
US8716249B2 (en) * | 2008-01-31 | 2014-05-06 | Energy Light Llc | Compositions and methods for improving cardiovascular health |
PL2274002T3 (pl) * | 2008-03-26 | 2015-06-30 | Glanbia Nutritionals Ireland Ltd | Kompozycje peptydów bogatych w leucynę i sposoby wydzielania |
US20090276229A1 (en) * | 2008-04-30 | 2009-11-05 | Martin Grigorov | Methods of monitoring the effect of nutritional products |
US20120178672A1 (en) * | 2009-03-18 | 2012-07-12 | Wolfe Robert R | Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis |
JP7123977B2 (ja) * | 2017-05-31 | 2022-08-23 | 協和発酵バイオ株式会社 | 筋量を増大させるためのシトルリンおよびグルタチオンの使用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5645839A (en) * | 1995-06-07 | 1997-07-08 | Trustees Of Boston University | Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis |
EP1079890A4 (en) * | 1998-05-08 | 2008-12-03 | Genetronics Inc | VASODILATION OF AN ELECTRICALLY INDUCED VESSEL |
US7737147B2 (en) * | 2000-07-27 | 2010-06-15 | Thomas Nadackal Thomas | Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors |
US7090858B2 (en) * | 2001-08-09 | 2006-08-15 | Swaminathan Jayaraman | Coated filter bag material for oral administration of medicament in liquid and methods of making same |
EP1581243A4 (en) * | 2002-12-06 | 2008-01-02 | Agennix Inc | ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES |
US20070172474A1 (en) * | 2004-04-02 | 2007-07-26 | University Of Tennessee Research Foundiation | Dairy components effective for fat loss |
-
2007
- 2007-03-20 UY UY30227A patent/UY30227A1/es not_active Application Discontinuation
- 2007-03-20 US US11/688,731 patent/US20080038320A1/en not_active Abandoned
- 2007-03-20 AR ARP070101136A patent/AR059992A1/es unknown
- 2007-03-20 PE PE2007000307A patent/PE20080037A1/es not_active Application Discontinuation
- 2007-03-20 WO PCT/US2007/064432 patent/WO2007109681A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20080038320A1 (en) | 2008-02-14 |
WO2007109681A2 (en) | 2007-09-27 |
WO2007109681A3 (en) | 2007-11-08 |
PE20080037A1 (es) | 2008-04-04 |
AR059992A1 (es) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30227A1 (es) | Composiciones y métodos para aumentar la vasodilatacion | |
MX2010004803A (es) | Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas. | |
FR2971512B1 (fr) | Compositions binaires de 2,3,3,3-tetrafluoropropene et d'ammoniac | |
EA037285B8 (ru) | Липиды и композиции для доставки лекарственных средств | |
EA202091230A3 (ru) | Антагонисты активин-actrii и их применения для повышения уровней эритроцитов | |
MX2014011459A (es) | Proteinas nutritivas cargadas y metodos. | |
GB201112382D0 (en) | Curable compositions and membranes | |
MY164415A (en) | Engineered fibers for well treatments | |
AR068485A1 (es) | Plantas con rendimiento incrementado | |
ZA200903305B (en) | Concentrated Surfactant Compositions | |
TW201144299A (en) | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | |
WO2008006895A3 (en) | Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators | |
EA200870515A1 (ru) | Моноциклические гетероарильные соединения | |
EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
FR2976289B1 (fr) | Compositions binaires de 1,3,3,3-tetrafluoropropene et d'ammoniac | |
GT200800068A (es) | Tipo de brocoli que contiene inflorescencia con flósculos separados. | |
CR20110011A (es) | Sustratos que tienen formulaciones con transferibilidad mejorada. | |
DOP2010000329A (es) | Inhibidores de la renina | |
NZ630990A (en) | Aminoacid lipids | |
MX2013007665A (es) | Composiciones vulcanizables basadas en cauchos de nitrilo que contienen grupos epoxi. | |
UA100394C2 (en) | Lipoic acid pellet composition | |
EA201201406A1 (ru) | Фунгицидные смеси ii, содержащие хиназолины | |
TR201901921T4 (tr) | Oyun taşları. | |
BR112012016054A2 (pt) | Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico | |
ATE512660T1 (de) | Zusammensetzungen mit peg-interferon-alpha- konjugaten und raffinose als kryoschutzmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170602 |